Biomarkers in Small Intestine NETs and Carcinoid Heart Disease: A Comprehensive Review
Biomarkers remain a valuable tool for the diagnosis and management of Neuroendocrine tumors (NETs). Traditional monoanalyte biomarkers such as Chromogranin A (CgA) and 5-Hydrocyondoleacetic acid (5-HIAA) have been widely used for many years as diagnostic, predictive and prognostic biomarkers in the...
Main Authors: | Markos Kalligeros, Leonidas Diamantopoulos, Christos Toumpanakis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/10/10/950 |
Similar Items
-
Neuroendocrine tumor of the small bowel and carcinoid syndrome: difficulties in diagnosis: a case report
by: E. O. Rodionov, et al.
Published: (2022-06-01) -
Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies
by: Leonidas N. Diamantopoulos, et al.
Published: (2023-07-01) -
Emerging Immunotherapeutic and Diagnostic Modalities in Carcinoid Tumors
by: Shahnaz D. Vellani, et al.
Published: (2023-02-01) -
Small Bowel Carcinoids: A Single Surgeon’s Experience in Southern India
by: Sreevathsa Maddibande Ramachar, et al.
Published: (2015-11-01) -
Management Strategies and Outcomes for Small Intestinal Neuroendocrine Tumours with Involvement of the Superior Mesenteric Vessels: A Systematic Review
by: Elizabeth Kmiotek, et al.
Published: (2023-10-01)